Relationship between CHOP/GADD153 and unstable human carotid atherosclerotic plaque

Suping Wang1, Meiyan Zhang1, Zanhua Liu1

  • 1a Department of Neurology , Dalian Municipal Central Hospital , Dalian , China.

Abstract

Insights

C/EBP homologous protein (CHOP)/growth-arrest-and-DNA-damage-inducible gene 153 (GADD153) is elevated in unstable atherosclerotic plaques. This finding was independent of other factors that induce endoplasmic reticulum stress, highlighting CHOP/GADD153

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Cellular Stress Response

Background:

  • Endoplasmic reticulum stress (ERS) is linked to apoptosis and the signaling protein C/EBP homologous protein (CHOP)/growth-arrest-and-DNA-damage-inducible gene 153 (GADD153).
  • Atherosclerotic (AS) plaque instability is a critical concern in cardiovascular disease.

Purpose of the Study:

  • To investigate the role of CHOP/GADD153 in unstable AS plaque formation.
  • To isolate the effects of CHOP/GADD153 from confounding factors like diabetes, hypertension, and smoking.

Main Methods:

  • Carotid artery tissue samples from patients undergoing carotid endarterectomy were analyzed.
  • CHOP/GADD153 expression was quantified using immunohistochemistry and RT-PCR.
  • Samples were classified as stable or unstable AS plaques based on histologic criteria.

Main Results:

  • CHOP/GADD153 expression was significantly higher in unstable AS plaques compared to stable plaques (p < .05).
  • Positive immunostaining for CHOP/GADD153 was observed in macrophages and smooth muscle cells within unstable plaques.
  • The study included 32 patients, with 75% having unstable lesions.

Conclusions:

  • CHOP/GADD153 is significantly elevated in unstable atherosclerotic plaques.
  • This elevation is independent of other common inducers of endoplasmic reticulum stress.
  • CHOP/GADD153 may play a crucial role in the pathogenesis of unstable AS plaques.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
826
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
496
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
650